세계의 자동 무균 샘플링 시장 : 업계 동향 및 예측 - 모니터링 방법별, 바이오프로세스 방법별, 작업량별, 확장 성별, 주요 지역별

GLOBAL AUTOMATIC ASEPTIC SAMPLING MARKET: OVERVIEW

As per Roots Analysis, the global automatic aseptic sampling market is estimated to grow from USD 157 million in the current year to USD 913 million by 2035, at a CAGR of 19.3% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Monitoring Method

• Online
• Off-line
• At-line

Bioprocessing Method

• Upstream
• Downstream

Working Volume

• Less than 10 ml
• 10-50 ml
• 51-100 ml
• More than 100 ml

Scalability

• Lab Scale
• Pilot Scale
• Commercial Scale

Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Rest of the World

GLOBAL AUTOMATIC ASEPTIC SAMPLING MARKET: GROWTH AND TRENDS

Accurate sampling is one of the most crucial processes during the production of pharmaceutical products. The conventional sampling approach or manual sampling techniques pose a risk of contamination and may result in operator-to-operator deviations during sample preparation and sampling. Furthermore, managing real-time data can be challenging for the labor enrolled in operational processes. Consequently, there is an increasing demand for sampling systems that allow accurate handling and aseptic sampling. In this context, an automatic aseptic sampling system emerges as an ideal solution for accurate sampling, minimizing errors, and real-time data monitoring.

Notably, the implementation of automated aseptic sampling systems helps to reduce deviation by around 65% and improve overall productivity by up to 80%. Further, owing to the significance offered by automated sampling systems, several pharmaceutical companies have begun to adopt these systems for seamless, error-free sampling operations. As a result, the automated aseptic sampling market is anticipated to grow during the forecast period driven by its wide-scale adoption.

GLOBAL AUTOMATIC ASEPTIC SAMPLING MARKET: KEY INSIGHTS

The report delves into the current state of global automatic aseptic sampling market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Presently, more than 55 automatic sampling systems are commercially available in different regions of the globe; a relatively larger proportion of these players are mid-sized companies.
• Majority of the automatic sampling systems (83%) allow on-line real-time monitoring and continuous process control; pharma and biotech companies have emerged as the most prominent end users of these systems.

• More than 80% of the automatic sample collection / preparation system manufacturers were established before 2000; majority of them are based in North America.
• In pursuit of building a competitive edge, stakeholders in this domain are striving to enhance their product portfolio and upgrade their automatic sampling systems with advanced features.
• Over 400 patents related to automatic sampling in biopharmaceutical industry have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field.
• The number of patents filed in this domain has increased at a CAGR of 40% since 2018; close to 30% of the patents have been filed in the last 12 months.
• The growing interest of stakeholders is also reflected by the events organized for automatic sampling systems, providing product developers with the opportunity to share their ideas and develop a better understanding of such systems.
• Over 35% of the partnerships were signed for product distribution purposes; stakeholders based in North America have signed maximum agreements related to automatic sampling.
• The increasing adoption of automatic sampling systems in the biopharmaceutical industry is anticipated to create profitable business opportunities for the system manufacturers.
• Given the requirement of systems that can transfer bioprocess samples directly from bioreactors to analyzers while maintaining the process sterility, the adoption of automatic sampling is anticipated to rise significantly.

• The market is likely to grow at an annualized rate of more than 19.3% by 2035; the opportunity is likely to be well distributed across different geographies, and other important market segments.

GLOBAL AUTOMATIC ASEPTIC SAMPLING MARKET: KEY SEGMENTS

The Online Segment Occupies the Largest Share of the Automatic Aseptic Sampling Market

Based on type of monitoring method, the market is segmented into online, off-line and at-line. At present, the online segment holds the majority share (~60%) of the global automatic aseptic sampling market. Additionally, the at-line segment is likely to grow at a faster pace compared to the other segments.

By Working Volume, 51-100 ml is the Fastest Growing Segment of the Global Automatic Aseptic Sampling Market

Based on the working volume, the market is segmented into less than 10 ml, 10-50 ml, 51-100 ml, and more than 100 ml. Currently, the 10-50 ml segment captures the highest proportion (~40%) of the global automatic aseptic sampling market. It is worth highlighting that the automatic aseptic sampling market for 51-100 ml segment is likely to grow at a relatively higher CAGR.

Upstream Segment Occupy the Largest Share of the Automatic Aseptic Sampling Market

Based on the bioprocessing method, the market is segmented into upstream and downstream. At present, the upstream segment holds the maximum share (~60%) of the automatic aseptic sampling market. In addition, this segment is likely to grow at a relatively higher CAGR.

By Scalability, the Pilot Scale Segment is the Fastest Growing Segment of the Automatic Aseptic Sampling Market During the Forecast Period

Based on the scalability, the market is segmented into lab scale, pilot scale, and commercial scale. Currently, lab scale segment captures the highest proportion (~50%) of the automatic aseptic sampling market. Further, it is worth highlighting that the automatic aseptic sampling market for pilot scale is likely to grow at a relatively higher CAGR.

North America Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Currently, North America (~55%) dominates the automatic aseptic sampling market and accounts for the largest revenue share. However, the market in Asia-Pacific is expected to grow at a higher CAGR.

Example Players in the Automatic Aseptic Sampling Market

• Agilent Technologies
• Biotage
• Cytiva
• Flownamics
• MGI Tech
• Mettler Toledo
• Pall Corporation
• Shimadzu
• SOTAX

GLOBAL AUTOMATIC ASEPTIC SAMPLING MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global automated liquid handling systems market, focusing on key market segments, including [A] type of monitoring method, [B] bioprocessing method, [C] working volume, [D] scalability and [E] key geographical regions.
• Automatic Sampling Systems Market Landscape: A comprehensive evaluation of automatic sampling systems, considering various parameters, such as [A] type of monitoring method, [B] type of sampling unit(s), [C] availability of pump / probe, [D] type of module, [E] automated software, [F] type of vessel, [G] vessel fabrication material, [H] type of analyte monitored, [I] type of analyzer, [J] number of sampling vessels, [K] working volume, [L] operating temperature, [M] end-user industry, [N] scalability and [O] applications of the system. Additionally, the module presents comprehensive analysis of automatic sampling system developers, based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] leading players (in terms of number of systems being offered).
• Automatic Sampling System Manufacturers Competitiveness Analysis: A comprehensive competitive analysis of automatic sampling systems manufacturers, examining factors, such as [A] overall experience of the company, [B] product portfolio strength and [C] portfolio diversity.
• Automatic Sampling System Company Profiles: In-depth profiles of companies engaged in the automatic aseptic sampling market, focusing on [A] company overviews, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
• Automatic Sample Collection / Preparation System Manufacturers Market Landscape: A comprehensive evaluation of automatic sample collection / preparation systems, considering various parameters, such as [A] system category, [B] system classification, [C] type of monitoring method, [D] type of sampling unit, [E] type of module, [F] working volume, [G] type of analyzer, [H] end-user industry and [I] scalability of the products. Additionally, a comprehensive analysis of players engaged in developing automatic sample collection / preparation systems, based on [A] year of establishment, [B] company size and [C] location of headquarters.
• Automatic Sample Collection / Preparation System Company Profiles: In-depth profiles of companies offering automatic sample collection / preparation systems, focusing on [A] company overviews, [B] product portfolio and [C] recent developments and an informed future outlook.
• Patent Analysis: An in-depth analysis of patents filed / granted till date in the automatic sampling systems domain, based on various relevant parameters, such as [A] type of patent, [B] publication year, [C] geographical location, [D] CPC symbols, [E] emerging focus areas, [F] type of organization, [G] leading players (in terms of number of patents granted / filed in the given time period), [H] patent characteristics, [I] patent benchmarking and [J] patent valuation.
• Recent Developments: An in-depth analysis of various developments / recent trends related to automatic sampling systems, providing insights on recent global events related to automatic sampling systems and partnerships and collaborations established within the domain.
• SWOT Analysis: An analysis of industry affiliated trends, opportunities and challenges, which are likely to impact the evolution of automatic sampling systems market; it includes a Harvey ball analysis, assessing the relative impact of each SWOT parameter on industry dynamics.
• PORTER'S Five Forces Analysis: A detailed analysis of the five competitive forces prevalent in automatic sampling systems market, including [A] threats of new entrants, [B] bargaining power of customers, [C] bargaining power of automatic sampling system manufacturers, [C] threats of substitute products and [D] rivalry among existing competitors.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Process Analytical Technology in Sampling
• 3.3. Manual Sampling versus Automatic Sampling
• 3.4. Need for Automatic Sampling Systems
• 3.5. Automatic Aseptic Sampling System
• 3.6. Components of a Sampling System
• 3.7. Stand-alone Systems versus Integrated Systems
• 3.8. Bioprocess Monitoring and Control Methods
  • 3.8.1. At-line Monitoring
  • 3.8.2. In-line Monitoring
  • 3.8.3. Off-line Monitoring
  • 3.8.4. On-line Monitoring
• 3.9. Key Considerations for Automatic Sampling
  • 3.9.1. Sample Volume
  • 3.9.2. Cell Removal
  • 3.9.3. Sampling Rate
  • 3.9.4. Integration of Analyzers
  • 3.9.5. Feedback to Bioreactor
  • 3.9.6. Flexibility
  • 3.9.7. Transferability
  • 3.9.8. Price
• 3.10. Benefits of Automatic Sampling Systems
• 3.11. Standards and Requirements
• 3.12. Future Innovations

4. MARKET LANDSCAPE: AUTOMATIC SAMPLING SYSTEMS

• 4.1. Chapter Overview
• 4.2. Automatic Sampling Systems: Overall Market Landscape
  • 4.2.1. Analysis by Type of Monitoring Method
  • 4.2.2. Analysis by Type of Sampling Unit
  • 4.2.3. Analysis by Availability of Pump / Probe
  • 4.2.4. Analysis by Type of Module
  • 4.2.5. Analysis by Automated Software
  • 4.2.6. Analysis by Type of Vessel
  • 4.2.7. Analysis by Vessel Fabrication Material
  • 4.2.8. Analysis by Type of Analyte Monitored
  • 4.2.9. Analysis by Type of Analyzer
  • 4.2.10. Analysis by Number of Sampling Vessels
  • 4.2.11. Analysis by Working Volume
  • 4.2.12. Analysis by Operating Temperature
  • 4.2.13. Analysis by End User Industry
  • 4.2.14. Analysis by Scalability
  • 4.2.15. Analysis by Application(s)
• 4.3. List of Automatic Sampling System Manufacturers
  • 4.3.1. Analysis by Year of Establishment
  • 4.3.2. Analysis by Company Size
  • 4.3.3. Analysis by Region of Headquarters
  • 4.3.4. Analysis by Company Size and Region of Headquarters
  • 4.3.5. Analysis by Location of Headquarters
  • 4.3.6. Leading Players: Analysis by Number of Automatic Sampling Systems Manufactured
  • 4.3.7. Leading Automatic Sampling System Manufacturers: Analysis by Number of End User Industries

5. COMPANY COMPETITIVENESS ANALYSIS

• 5.1. Chapter Overview
• 5.2. Assumptions / Key Parameters
• 5.3. Scope and Methodology
• 5.4. Company Competitiveness Analysis: Automatic Sampling System Manufacturers in North America
• 5.5. Company Competitiveness Analysis: Automatic Sampling System Manufacturers in Europe
• 5.6. Company Competitiveness Analysis: Automatic Sampling System Manufacturers in Asia-Pacific

6. COMPANY PROFILES: AUTOMATIC SAMPLING SYSTEM MANUFACTURERS

• 6.1. Chapter Overview
• 6.2. Agilent Technologies
  • 6.2.1. Company Overview
  • 6.2.2. Financial Information
  • 6.2.3. Product Portfolio
  • 6.2.4. Recent Developments and Future Outlook
• 6.3. Cytiva
  • 6.3.1. Company Overview
  • 6.3.2. Product Portfolio
  • 6.3.3. Recent Developments and Future Outlook
• 6.4. Mettler Toledo
  • 6.4.1. Company Overview
  • 6.4.2. Financial Information
  • 6.4.3. Product Portfolio
  • 6.4.4. Recent Developments and Future Outlook
• 6.5. Pall Corporation
  • 6.5.1. Company Overview
  • 6.5.2. Product Portfolio
  • 6.5.3. Recent Developments and Future Outlook
• 6.6. Shimadzu
  • 6.6.1. Company Overview
  • 6.6.2. Financial Information
  • 6.6.3. Product Portfolio
  • 6.6.4. Recent Developments and Future Outlook
• 6.7. Xylem
  • 6.7.1. Company Overview
  • 6.7.2. Financial Information
  • 6.7.3. Product Portfolio
  • 6.7.4. Recent Developments and Future Outlook

7. MARKET LANDSCAPE: AUTOMATIC SAMPLE COLLECTION / PREPARATION SYSTEMS

• 7.1. Chapter Overview
• 7.2. Automatic Sample Collection / Preparation Systems: Overall Market Landscape
  • 7.2.1. Analysis by System Category
  • 7.2.2. Analysis by System Classification
  • 7.2.3. Analysis by Type of Monitoring Method
  • 7.2.4. Analysis by Type of Sampling Unit
  • 7.2.5. Analysis by Type of Module
  • 7.2.6. Analysis by Working Volume
  • 7.2.7. Analysis by Type of Analyzer
  • 7.2.8. Analysis by End User Industry
  • 7.2.9. Analysis by Scalability
• 7.3. List of Automatic Sample Collection / Preparation System Manufacturers
  • 7.3.1. Analysis by Year of Establishment
  • 7.3.2. Analysis by Company Size
  • 7.3.3. Analysis by Region of Headquarters
  • 7.3.4. Analysis by Company Size and Region of Headquarters
  • 7.3.5. Analysis by Location of Headquarters
  • 7.3.6. Leading Players: Analysis by Number of Automatic Sample Collection / Preparation Systems Manufactured

8. COMPANY PROFILES: AUTOMATIC SAMPLE COLLECTION / PREPARATION SYSTEM MANUFACTURERS

• 8.1. Chapter Overview
• 8.2. Agilent Technologies
  • 8.2.1. Company Overview
  • 8.2.2. Product Portfolio
  • 8.2.3. Recent Developments and Future Outlook
• 8.3. Biotage
  • 8.3.1. Company Overview
  • 8.3.2. Product Portfolio
  • 8.3.3. Recent Developments and Future Outlook
• 8.4. Flownamics
  • 8.4.1. Company Overview
  • 8.4.2. Product Portfolio
  • 8.4.3. Recent Developments and Future Outlook
• 8.5. MGI Tech
  • 8.5.1. Company Overview
  • 8.5.2. Product Portfolio
  • 8.5.3. Recent Developments and Future Outlook
• 8.6. SOTAX
  • 8.6.1. Company Overview
  • 8.6.2. Product Portfolio
  • 8.6.3. Recent Developments and Future Outlook

9. PATENT ANALYSIS

• 9.1. Chapter Overview
• 9.2. Scope and Methodology
• 9.3. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Patent Analysis
  • 9.3.1. Analysis by Publication Year
  • 9.3.2. Analysis by Annual Number of Granted Patents and Patent Applications
  • 9.3.3. Analysis by Geographical Location
  • 9.3.4. Analysis by CPC Symbols
  • 9.3.5. Word Cloud: Emerging Focus Areas
  • 9.3.6. Analysis by Type of Organization
  • 9.3.7. Leading Industry Players: Analysis by Number of Patents
  • 9.3.8. Leading Non-Industry Players: Analysis by Number of Patents
  • 9.3.9. Leading Individual Assignees: Analysis by Number of Patents
• 9.4. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Patent Benchmarking Analysis
  • 9.4.1. Analysis by Patent Characteristics
• 9.5. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Patent Valuation Analysis
• 9.6. Leading Patents by Number of Citations

10. RECENT DEVELOPMENTS

• 10.1. Chapter Overview
• 10.2. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Partnership Activity
  • 10.2.1. Partnership Models
  • 10.2.2. List of Partnerships and Collaborations
    • 10.2.2.1. Analysis by Year of Partnership
    • 10.2.2.2. Analysis by Type of Partnership
    • 10.2.2.3. Analysis by Type of Product
    • 10.2.2.4. Analysis by Product and Type of Partnership
    • 10.2.2.5. Most Active Players: Analysis by Number of Partnerships
    • 10.2.2.6. Word Cloud: Emerging Focus Areas
    • 10.2.2.7. Regional Analysis
    • 10.2.2.8. Intercontinental and Intracontinental Agreements
• 10.3. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Global Events
  • 10.3.1. List of Global Events
    • 10.3.1.1. Analysis by Year of Event
    • 10.3.1.2. Analysis by Event Platform
    • 10.3.1.3. Analysis by Type of Event
    • 10.3.1.4. Analysis by Geography
    • 10.3.1.5. Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Area
    • 10.3.1.6. Most Active Participants: Analysis by Number of Events
    • 10.3.1.7. Analysis by Seniority Level of Event Speakers
• 10.4. Concluding Remarks

11. SWOT ANALYSIS

• 11.1. Chapter Overview
• 11.2. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: SWOT Analysis
  • 11.2.1. Comparison of SWOT Factors

12. PORTERS FIVE FORCES ANALYSIS

• 12.1. Chapter Overview
• 12.2. Methodology and Assumptions
• 12.3. Key Parameters
  • 12.3.1. Threats of New Entrants
  • 12.3.2. Bargaining Power of Customers
  • 12.3.3. Bargaining Power of Automatic Sampling System Manufacturers
  • 12.3.4. Threats of Substitute Products
  • 12.3.5. Rivalry Among Existing Competitors
• 12.4. Concluding Remarks

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

• 13.1. Chapter Overview
• 13.2. Key Assumptions and Methodology
• 13.3. Global Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market, Till 2035
  • 13.3.1. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market: Distribution by Type of Monitoring Method
    • 13.3.1.1. Automatic Sampling Market for On-line Monitoring, Till 2035
    • 13.3.1.2. Automatic Sampling Market for Off-line Monitoring, Till 2035
    • 13.3.1.3. Automatic Sampling Market for At-line Monitoring, Till 2035
  • 13.3.2. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market: Distribution by Type of Bioprocessing Method
    • 13.3.2.1. Automatic Sampling Market for Upstream Bioprocessing, Till 2035
    • 13.3.2.2. Automatic Sampling Market for Downstream Bioprocessing, Till 2035
  • 13.3.3. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market: Distribution by Working Volume
    • 13.3.3.1. Automatic Sampling Market for Systems with less than 10 mL Working Volume, Till 2035
    • 13.3.3.2. Automatic Sampling Market for Systems with 10-50 mL Working Volume, Till 2035
    • 13.3.3.3. Automatic Sampling Market for Systems with 51-100 mL Working Volume, Till 2035
    • 13.3.3.4. Automatic Sampling Market for Systems with more than 100 mL Working Volume, Till 2035
  • 13.3.4. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market: Distribution by Scalability
    • 13.3.4.1. Automatic Sampling Market for Lab Scale Operations, Till 2035
    • 13.3.4.2. Automatic Sampling Market for Pilot Scale Operations, Till 2035
    • 13.3.4.3. Automatic Sampling Market for Commercial Scale Operations, Till 2035
  • 13.3.5. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market: Distribution by Key Geographical Regions
    • 13.3.5.1. Automatic Sampling Market in North America, Till 2035
    • 13.3.5.2. Automatic Sampling Market in Europe, Till 2035
    • 13.3.5.3. Automatic Sampling Market in Asia-Pacific and Rest of the World, Till 2035

14. INDUSTRIAL REVOLUTION FROM INDUSTRY 1.0 TO INDUSTRY 5.0

• 14.1. Chapter Overview
• 14.2. Transition from Industry 1.0 to Industry 5.0
  • 14.2.1. Industry 1.0
  • 14.2.2. Industry 2.0
  • 14.2.3. Industry 3.0
  • 14.2.4. Industry 4.0
  • 14.2.5. Industry 5.0
• 14.3. Horizons of Lab Evolution
• 14.4. Benefits of Industry 4.0
• 14.5. Benefits of Industry 5.0
• 14.6. Concluding Remarks

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS